US Food and Drug Administration commissioner Robert Califf was the keynote speaker to open the second morning of the J.P. Morgan Healthcare Conference in San Francisco – and he took the opportunity to get a point across to industry about relying on clinical trials that are run outside the US for drugs intended for the US population.
“I’m 100% in favor of globalization. I’m 100% opposed to offshoring as a financial arbitrage,” he said during his 10...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?